Mount Sinai - PRIME — Linden, New Jersey

Mount Sinai - PRIME is a clinical research site located in Linden, New Jersey, United States 07036.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mount Sinai - PRIME has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Linden

Browse all research sites in New Jersey · View every site in Linden

• NJ Heart
• New Jersey Heart
• Research Site
• GSK Investigational Site
• NJ MedCare & NJ Heart
• Pfizer Investigational Site
• Investigator Site 11-054
• Linden Meals on Wheels
• Local Institution - 0334
• Investigational Site Number 8400020
• NJ Heart | Linden, NJ
• Forest Investigative Site 1141

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai - PRIME?

Mount Sinai - PRIME has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai - PRIME conducted?

Mount Sinai - PRIME has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Mount Sinai - PRIME accredited by Crixeo Clinical Trials?

Mount Sinai - PRIME has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai - PRIME?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.